These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Post-remission treatment for adult patients with acute lymphoblastic leukemia in first remission: is there a role for autologous stem cell transplantation? Willemze R; Labar B Semin Hematol; 2007 Oct; 44(4):267-73. PubMed ID: 17961726 [TBL] [Abstract][Full Text] [Related]
29. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials. Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891 [TBL] [Abstract][Full Text] [Related]
30. Augmented antitumor activity against B-cell lymphoma by a combination of monoclonal antibodies targeting TRAIL-R1 and CD20. Maddipatla S; Hernandez-Ilizaliturri FJ; Knight J; Czuczman MS Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4556-64. PubMed ID: 17671142 [TBL] [Abstract][Full Text] [Related]
31. New therapeutic strategies for the treatment of acute lymphoblastic leukaemia. Pui CH; Jeha S Nat Rev Drug Discov; 2007 Feb; 6(2):149-65. PubMed ID: 17268486 [TBL] [Abstract][Full Text] [Related]
32. Use of rituximab in diffuse large B-cell lymphoma in the salvage setting. Gisselbrecht C Br J Haematol; 2008 Dec; 143(5):607-21. PubMed ID: 18950460 [TBL] [Abstract][Full Text] [Related]
33. [Acute lymphoblastic leukemia (ALL)]. Imai K; Akiyama H Gan To Kagaku Ryoho; 2007 Dec; 34(13):2180-4. PubMed ID: 18079617 [TBL] [Abstract][Full Text] [Related]
35. Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma: a single-centre study of 20 patients. Aydin S; Dührsen U; Nückel H Ann Hematol; 2007 Apr; 86(4):271-6. PubMed ID: 17216473 [TBL] [Abstract][Full Text] [Related]
36. Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhood. Mussolin L; Pillon M; Conter V; Piglione M; Lo Nigro L; Pierani P; Micalizzi C; Buffardi S; Basso G; Zanesco L; Rosolen A J Clin Oncol; 2007 Nov; 25(33):5254-61. PubMed ID: 18024872 [TBL] [Abstract][Full Text] [Related]
37. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92. Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047 [TBL] [Abstract][Full Text] [Related]
38. Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy. Jaime-Pérez JC; Rodríguez-Romo LN; González-Llano O; Chapa-Rodríguez A; Gómez-Almaguer D Br J Haematol; 2009 Mar; 144(5):794-5. PubMed ID: 19036096 [No Abstract] [Full Text] [Related]
39. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab]. Al-Ali HK; Wittekind C; Niederwieser D Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864 [TBL] [Abstract][Full Text] [Related]
40. Simultaneous study of five candidate target antigens (CD20, CD22, CD33, CD52, HER2) for antibody-based immunotherapy in B-ALL: a monocentric study of 44 cases. Chevallier P; Robillard N; Houille G; Ayari S; Guillaume T; Delaunay J; Harousseau JL; Avet-Loiseau H; Mohty M; Garand R Leukemia; 2009 Apr; 23(4):806-7. PubMed ID: 18971949 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]